Fig. 12.1 Hepatocellular carcinoma treatment algorithm. HCC hepatocellular carcinoma, CTP Child-Turcotte-Pugh, TACE transarterial chemoembolization, PH portal hypertension, Bili bilirubin; Orange outline indicates palliative treatments only Colorectal Liver Metastases While older…
© Springer International Publishing AG 2017Bijan Eghtesad and John Fung (eds.)Surgical Procedures on the Cirrhotic Patient10.1007/978-3-319-52396-5_10 10. Cholecystitis, Cholelithiasis, and Cholecystectomy in Cirrhotic Patients Kenneth D. Chavin1 , Gabriel R. Chedister2 , Vinayak S. Rohan2 and Arun P. Palanisamy1 (1) Department of Surgery, Case Western…
© Springer International Publishing AG 2017Bijan Eghtesad and John Fung (eds.)Surgical Procedures on the Cirrhotic Patient10.1007/978-3-319-52396-5_9 9. Role of Minimally Invasive Surgery in Patients with Cirrhosis Naftali Presser1 and Jeffery L. Ponsky2, 3 (1) Department of General Surgery,…
Clinical/biochemical indicator 1 point 2 points 3 points Serum bilirubin (mg/dL) <2 2–3 >3 Serum albumin (g/dL) >3.5 2.8–3.5 <2.8 Prothrombin time (s > control) <4 4–6 >6 Encephalopathy (grade)…
© Springer International Publishing AG 2017Bijan Eghtesad and John Fung (eds.)Surgical Procedures on the Cirrhotic Patient10.1007/978-3-319-52396-5_8 8. Perioperative Critical Care of the Patient with Liver Disease Undergoing Nonhepatic Surgery David J. Kramer1, 2 (1) Aurora Critical Care…
Diagnosis Screening method Perioperative consequences Cirrhotic cardiomyopathy (CCM) Echocardiography assessment of LV diastolic function Congestive heart failurea Hepatopulmonary syndrome (HPS) Room air hypoxemia (PaO2 <70 mmHg) in the absence of…
Phase of hemostasis Promote hemostasis Impair hemostasis Primary hemostasis (platelet activation) Increased VWF Decreased ADAMTS-13 Thrombocytopenia Secondary hemostasis (thrombin generation) Decreased protein C and S Decreased antithrombin III Increased factor…
